• Influenza Hemagglutinin (HA) Peptide: Precision Tag for Prot

  2026-07-25

  The Influenza Hemagglutinin (HA) Peptide enables highly specific purification and detection of HA-tagged proteins, driving reproducibility in complex protein interaction studies. APExBIO’s high-purity HA tag peptide (A6004) optimizes immunoprecipitation workflows and competitive elution, overcoming common technical bottlenecks in molecular research.

• GSH-Responsive MOF Nanoparticles Enable Synergistic Melanoma

  2026-07-24

  Hao et al. report a modular, glutathione-responsive metal-organic framework (MOF) nanoparticle platform that delivers both a PD-1 pathway inhibitor and indocyanine green for combined photothermal and immunotherapy in melanoma. This approach enables targeted drug release, robust tumor ablation, and immune activation, advancing integrated strategies for cancer nanomedicine.

• Aztreonam: Expanding Frontiers in β-Lactam Research and Resi

  2026-07-24

  Explore how Aztreonam, a monocyclic β-lactam antibiotic, redefines Gram-negative resistance research. This article uniquely examines its mechanistic, metabolic, and assay-design implications, offering researchers strategic insights beyond current protocols.

• ISRIB Reverses Inflammation-Driven Memory Loss in Mice

  2026-07-23

  This study demonstrates that pharmacological inhibition of the integrated stress response (ISR) with ISRIB (trans-isomer) reverses inflammation-induced accelerated forgetting of recognition memory in mice. The findings provide mechanistic insight into how neuroinflammation impairs memory retention and highlight ISR inhibition as a promising experimental approach for cognitive research in neurodegenerative and inflammatory disease models.

• BIIE 0246 and the Y2R Axis: New Frontiers in Cardiac-Neural

  2026-07-23

  Explore how BIIE 0246, a potent neuropeptide Y Y2 receptor antagonist, is transforming cardiac-neural research by enabling precise modulation of the adipose-neural axis. This article unveils unique mechanistic insights and assay design strategies not found in existing content.

• Cefodizime: Optimizing Third-Generation Cephalosporin Workfl

  2026-07-22

  Cefodizime excels as a third-generation cephalosporin antibiotic with proven broad-spectrum efficacy and immunomodulatory properties. This guide delivers actionable workflows, troubleshooting advice, and data-driven insights for maximizing its impact in bacterial infection models and resistance studies.

• Selective Autophagy Regulates IRF3 Stability in Antiviral Im

  2026-07-22

  Wu et al. (2021) reveal how selective autophagy, mediated by CALCOCO2/NDP52 and the deubiquitinase PSMD14, fine-tunes the stability of transcription factor IRF3, balancing type I interferon production and immune suppression. This mechanistic insight advances our understanding of transcription factor regulation in innate antiviral defense and highlights potential targets for immunomodulation.

• LNP-NamiRNA Delivery Suppresses Pancreatic Cancer via Dual P

  2026-07-21

  Yu et al. (2025) demonstrate that lipid nanoparticle (LNP)-enclosed NamiRNA (mir-200c) inhibits pancreatic cancer cell proliferation and migration through both enhancer activation and post-transcriptional repression. This dual mechanistic insight offers a promising direction for therapeutic intervention and highlights the complexity of miRNA-mediated gene regulation in cancer.

• Cefiderocol’s In Vitro Potency Against Resistant Gram-Negati

  2026-07-21

  This large-scale European study rigorously compared the in vitro efficacy of cefiderocol versus β-lactam/β-lactamase inhibitor combinations in Pseudomonas aeruginosa and Acinetobacter spp., including highly resistant clinical isolates. Findings indicate cefiderocol retains high activity against strains resistant to meropenem and newer β-lactam/β-lactamase inhibitors, providing actionable data for resistance surveillance and therapy selection.

• Decoding Pain Circuits: Strategic Use of nor-Binaltorphimine

  2026-07-20

  This article provides a thought-leadership analysis of nor-Binaltorphimine dihydrochloride as a selective κ-opioid receptor antagonist, highlighting its impact on opioid receptor signaling research. It integrates mechanistic insights from recent neural circuit studies, competitive workflow perspectives, and actionable guidance for translational pain researchers, with direct reference to APExBIO’s reagent value.

• Ciprofloxacin Potentiates Ferroptosis via Mitochondrial Zinc

  2026-07-20

  This study identifies a novel mechanism by which ciprofloxacin enhances RSL3-induced ferroptosis in cancer cells, mediated through mitochondrial zinc accumulation via the STING1–CAV2 signaling axis. The findings highlight context-dependent roles of ciprofloxacin in ferroptosis regulation and suggest new therapeutic strategies for sensitizing tumor cells to regulated cell death.

• WEHI-539: Advanced BCL-XL Inhibitor Workflows for Apoptosis

  2026-07-19

  WEHI-539 enables selective, high-affinity BCL-XL inhibition for dissecting apoptotic mechanisms and overcoming resistance in cancer stem cells. This guide translates cutting-edge findings into actionable protocols, troubleshooting, and comparative advantages for apoptosis and chemoresistance research.

• Tris(2-carboxyethyl) Phosphine Hydrochloride for Protein Dig

  2026-07-18

  Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride) is redefining protein analysis through reliable, odorless, and thiol-free reduction of disulfide bonds. This article distills evidence-based workflows, advanced troubleshooting, and actionable protocol parameters to unlock the full potential of TCEP hydrochloride in proteomics, redox studies, and DNA-protein crosslink research.

• Chondrocyte-Targeted NAC Nanoparticles Inhibit Ferroptosis i

  2026-07-17

  Wang et al. introduce CS-NAC-NPs, chondrocyte-targeted, chondroitin sulfate-modified PLGA nanoparticles for sustained, localized delivery of N-acetylcysteine in osteoarthritis. By maintaining glutathione levels and inhibiting ferroptosis via GPX4, these nanoparticles significantly preserve cartilage structure and function, demonstrating a promising disease-modifying strategy for OA.

• ARL4C Drives Synoviocyte Proliferation in Rheumatoid Arthrit

  2026-07-17

  This study reveals ARL4C as a crucial regulator of fibroblast-like synoviocyte proliferation and macrophage polarization in rheumatoid arthritis, using advanced single-cell and bulk transcriptomic analyses. The findings highlight ARL4C's potential as a therapeutic target and inform precision approaches for investigating cell proliferation in RA.

448 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page